课题基金 / 基金详情

IMMUNOREACTIVE MACROMOLECULES IN COCCIDIOIDES CELL TYPES

IMMUNOREACTIVE MACROMOLECULES IN COCCIDIOIDES CELL TYPES
球孢子细胞类型中的免疫反应性大分子
批准号:
3128556
负责人:
GARRY Thomas COLE
金额:
$14.08万
依托单位国家:
美国
项目类别:
财政年份:
1986
资助国家:
美国
项目状态:
已结题
起止时间:
1986-09-01 至 1989-08-31

项目摘要

项目成果

GARRY Thomas COLE的其他基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Coccidioides immitis is a pathogenic fungus which is the causative agent of a primary respiratory infection of man and other animals. It is endemic to southwestern United States from California to Texas and its natural habitat is arid soil. The saprobic phase of this fungus releases infectious propagules, or, arthroconidia, into the air which are inhaled by the host. About 100,000 people are infected each year. Although less than half of these infections produce symptoms, those that do account for a significant amount of morbidity and mortality. The latter is limited to individuals who suffer extrapulmonary spread of the infection. This organism is unique among fungi in that the parasitic stage occurs in a repetitive morphogenetic cycle involving conversion of the propagule into a multinucleate spherule which subsequently cleaves internally to produce a myriad of tiny endospores. The latter disseminate within the host and convert into a new generation of spherules. These morphological forms are associated with different tissue responses; e.g., the spherules are associated primarily with granulomatous response and the relased endospores with suppurative response. Thus, C. immitis is an ideal model for examining the intricate mechanisms by which the host cells respond to the insult of the propagule and successive cell types of the parasitic cycle. Such host-pathogen interactions are poorly understood in this and other mycotic diseases. Evidence has been presented that antigenic composition of the cell envelope of C. immitis is altered during morphogenesis. Such changes may be related to variations in host response. Published data also indicate that clinically significant biological activities associated with this disease, including cell-mediated immune responses, reactivity with immununoglobulin antibody and immunoprotection against challenge in experimental animals are elicited by cell wall fractions. The aims of this project are to identify the antigenic composition and biological activity of fractionated soluble wall components of C. immitis cell types, prepare polycolonal and monoclonal antibodies to these fractions and assess the homogeneity of the fractions, determine the location and/or presentation of antigens on the cell envelope using cell surface probes, and evaluate the immunoprotective capacity of the fractions in experimental animals. The results of these studies will provide for improved immunodiagnosis of the various clinical manifestations of coccidioidomycosis as well as the basis for developing a human vaccine against this fungal disease.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
A Recombinant Protein Vaccine Against Coccidioidomycosis
  • 批准号:
    8082225
  • 项目类别:
  • 资助金额:
    $6.52万
  • 财政年份:
    2010
  • 负责人:
    GARRY Thomas COLE
  • 依托单位:
A Recombinant Protein Vaccine Against Coccidioidomycosis
  • 批准号:
    7577430
  • 项目类别:
  • 资助金额:
    $35.38万
  • 财政年份:
    2008
  • 负责人:
    GARRY Thomas COLE
  • 依托单位:
A Recombinant Protein Vaccine Against Coccidioidomycosis
  • 批准号:
    8019458
  • 项目类别:
  • 资助金额:
    $34.67万
  • 财政年份:
    2008
  • 负责人:
    GARRY Thomas COLE
  • 依托单位:
A Recombinant Protein Vaccine Against Coccidioidomycosis
  • 批准号:
    7463462
  • 项目类别:
  • 资助金额:
    $35.38万
  • 财政年份:
    2008
  • 负责人:
    GARRY Thomas COLE
  • 依托单位: